Lista de obras - Harvey D. White - Dominio Público Uruguay

"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction

scientific article published on 01 January 1995

2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006.

artículo científico publicado en 2008

2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006.

artículo científico publicado en 2011

2212Body mass index and its association to cardiovascular outcomes in patients with stable coronary heart disease - experiences from the STABILITY study ⬇️

artículo científico publicado en 2019

30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18).

artículo científico

A case of cardiogenic shock caused by capecitabine treatment

artículo científico publicado en 2008

A catalog of genetic loci associated with kidney function from analyses of a million individuals

scientific article published on 31 May 2019

A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012

artículo científico publicado en 2017

A direct threat to research in public hospitals

scientific article published on 01 August 1995

A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

artículo científico publicado en 2010

A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement

artículo científico publicado en 2002

A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial

artículo científico publicado en 2013

A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction

artículo científico publicado en 1994

A randomized trial evaluating the effects of change in dairy food consumption on cardio-metabolic risk factors.

artículo científico publicado en 2013

A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis

artículo científico publicado en 2008

A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction

artículo científico publicado en 2003

A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry

artículo científico publicado en 2010

A simulation of warfarin maintenance dose requirement using a pharmacogenetic algorithm in an ethnically diverse cohort

artículo científico publicado en 2010

A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes

scientific article published on 12 September 2006

ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients

artículo científico publicado en 2010

Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity

artículo científico publicado en 1998

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial

artículo científico publicado en 1996

Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale

artículo científico publicado en 2004

Acute Coronary Care in the Elderly, Part I

article by Karen P. Alexander et al published 15 May 2007 in Circulation

Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities.

artículo científico publicado en 2004

Acute Myocardial Infarction: Fibrinolytic Therapy

scientific article published on 01 February 2004

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Ger

artículo científico publicado en 2007

Acute myocardial infarction

scientific article published in The Lancet

Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry

artículo científico publicado en 2000

Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

artículo científico publicado en 1995

Acute myocardial infarction: a true medical emergency

artículo científico publicado en 1989

Acute reperfusion for ST-elevation myocardial infarction in New Zealand (2015-2017): patient and system delay (ANZACS-QI 29)

artículo científico publicado en 2019

Adding Insult to Injury: Are There Treatments for Myocardial Injury and Type 2 Myocardial Infarction?

artículo científico publicado en 2020

Adherence and outcomes: it's more than taking the pills

artículo científico publicado en 2005

Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective

artículo científico publicado en 2011

Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction

artículo científico publicado en 2004

Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

artículo científico publicado en 2009

After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the I

scientific article published on 01 November 1993

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.

artículo científico publicado en 1996

Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial

artículo científico publicado en 2012

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

artículo científico publicado en 2016

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

scientific article published on 11 November 2019

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial

artículo científico publicado en 2018

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

article

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial

artículo científico publicado en 2019

All-Cause Mortality Following an Acute Coronary Syndrome: 12-Year Follow-Up of the Comprehensive 2002 New Zealand Acute Coronary Syndrome Audit

artículo científico publicado en 2017

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

artículo científico publicado en 2004

Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction

artículo científico publicado en 1999

Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial ⬇️

artículo científico publicado el 1 de julio de 1992

Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction

artículo científico publicado en 2011

Antiplatelet drug nonresponsiveness

scientific article published on April 2008

Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction

artículo científico publicado en 2007

Antithrombin agents as adjuncts to thrombolytic therapy

artículo científico publicado en 1999

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

artículo científico

Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial

artículo científico publicado en 2009

Antithrombotic therapy in ST-segment elevation myocardial infarction ⬇️

artículo científico publicado el 1 de febrero de 2011

Apixaban with antiplatelet therapy after acute coronary syndrome

artículo científico publicado en 2011

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

artículo científico publicado en 2022

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

artículo científico publicado en 2015

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome

artículo científico publicado en 2015

Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction

artículo científico publicado en 1993

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

artículo científico publicado en 2003

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

artículo científico publicado en 2016

Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension

artículo científico publicado en 1993

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

artículo científico publicado en 2013

Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Isch

artículo científico publicado en 2013

Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy

artículo científico publicado en 2005

Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis

artículo científico publicado en 2011

Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes ⬇️

artículo científico publicado el 1 de mayo de 2003

Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation

artículo científico publicado en 2003

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

artículo científico publicado en 2017

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

artículo científico publicado en 2009

Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome

scientific article published on 18 September 2019

Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

artículo científico publicado en 2010

Availability of troponin testing for cardiac patients in New Zealand 2002 to 2011: implications for patient care.

artículo científico publicado en 2012

Avatar of the universal definition of periprocedural myocardial infarction

artículo científico publicado en 2013

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

artículo científico publicado en 2009

Benefit of Early Sustained Reperfusion in Patients With Prior Myocardial Infarction (The GUSTO-I Trial)

artículo científico publicado en 1998

Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy

artículo científico publicado en 2001

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

artículo científico publicado en 2017

Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study

artículo científico publicado en 2015

Bivalirudin for patients with acute coronary syndromes

artículo científico publicado en 2006

Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial

scientific article published on 01 March 2007

Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender

artículo científico publicado en 2002

Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery

artículo científico publicado en 2004

Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions

artículo científico publicado en 2002

Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal

artículo científico publicado en 2007

COMPARISON OF BLEEDING RISK PREDICTION MODELS WITH DUAL ANTI-PLATELET THERAPY TREATMENT AMONG PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED MEDICALLY WITHOUT REVASCULARIZATION

artículo científico publicado en 2019

Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium

artículo científico publicado en 2000

Candesartan and heart failure: the allure of CHARM.

artículo científico publicado en 2003

Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).

artículo científico publicado en 2017

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

artículo científico publicado en 2017

Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trials

artículo científico publicado en 2017

Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIX.

artículo científico publicado en 2017

Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial

artículo científico publicado en 2017

Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction.

artículo científico publicado en 2006

Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends

artículo científico

Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry

artículo científico publicado en 2003

Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

article by J S Hochman et al published September 2000 in Journal of the American College of Cardiology

Cardiogenic shock from left ventricular dysfunction complicating an acute ST-elevation myocardial infarction.

artículo científico publicado en 2009

Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).

artículo científico publicado en 2009

Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation

artículo científico publicado en 2005

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

artículo científico

Cardiovascular Outcomes With Alirocumab After Acute Coronary Syndrome: Results of the Odyssey Outcomes Trial

scholarly article

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

scientific article published on 26 August 2018

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Cardiovascular disease on a global scale: defining the path forward for research and practice

artículo científico publicado en 2007

Carvedilol: use in chronic heart failure

artículo científico publicado en 2007

Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention

scientific article published on 12 July 2019

Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study

artículo científico publicado en 2013

Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial

artículo científico publicado en 2018

Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.

artículo científico publicado en 2017

Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

artículo científico publicado en 2018

Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes

artículo científico publicado en 2005

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

artículo científico publicado en 2002

Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements

scientific article published on 10 April 2020

Clarifying the Proper Definitions for Type 2 Myocardial Infarction

artículo científico publicado en 2018

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial

artículo científico publicado en 2021

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy

article

Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial

artículo científico publicado en 2010

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2017

Clinical implications of the Third Universal Definition of Myocardial Infarction

artículo científico

Clinical implications of the new definition of myocardial infarction

artículo científico publicado en 2004

Clinical outcomes of bivalirudin for ischemic heart disease

artículo científico publicado en 1999

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

artículo científico publicado en 1998

Clinically Important Improvements in Risk Assessment by Adding High-Sensitivity Troponin Level to Cholesterol Guidelines

artículo científico publicado en 2020

Combination therapy with tirofiban and enoxaparin in acute coronary syndromes

artículo científico publicado en 1999

Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: variation by country beyond predictive profile. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mor

artículo científico publicado en 1993

Comparative tolerability profiles of thrombolytic agents. A review

artículo científico publicado en 1993

Comparing health expenditure

scientific article published on 01 October 1996

Comparing health expenditure

scientific article published on 01 January 1997

Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management

artículo científico publicado en 2021

Comparison of Octogenarians and Septuagenarians Undergoing Coronary Artery Bypass Surgery

scholarly article

Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population

artículo científico publicado en 2012

Comparison of aspirin with a thromboxane antagonist for patients with prolonged chest pain and ST segment depression

scientific article published on 01 July 1996

Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention

Comparison of case fatality in smokers and non-smokers after acute cardiac event ⬇️

artículo científico publicado el 18 de octubre de 1997

Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).

artículo científico publicado en 2010

Comparison of four risk scores for contemporary isolated coronary artery bypass grafting

artículo científico publicado en 2013

Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis

artículo científico publicado en 2011

Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial)

artículo científico publicado en 2011

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

artículo científico publicado en 2007

Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone

article

Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (S

artículo científico publicado en 2005

Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus

artículo científico publicado en 2008

Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk

artículo científico publicado en 1991

Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

artículo científico publicado en 2012

Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators

artículo científico publicado en 1996

Complex valve disease: pre-surgical functional capacity evaluation using peak oxygen consumption

artículo científico publicado en 2009

Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease

artículo científico publicado en 2010

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition

artículo científico publicado en 2015

Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO)

artículo científico publicado el 1 de mayo de 1992

Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).

artículo científico publicado en 2016

Coronary Artery Patency and Survival in Clinical Trials

artículo científico publicado en 1997

Coronary artery bypass graft surgery in New Zealand's Auckland region: a comparison between the clinical priority assessment criteria score and the actual clinical priority assigned

artículo científico publicado en 2006

Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict

artículo científico publicado en 2008

Coronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health Conference

artículo científico publicado en 2010

Coronary intervention for persistent occlusion after myocardial infarction

artículo científico publicado en 2006

Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy

artículo científico publicado en 2001

Cost Effectiveness of Early Discharge after Uncomplicated Acute Myocardial Infarction

article

Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study

scientific article published on 04 May 2018

Cost of coronary heart disease in New Zealand.

artículo científico publicado en 1993

Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial

artículo científico publicado en 2020

Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: Results from the LIPID study

Current guidelines for the management of unstable angina: a new diagnostic and management paradigm

artículo científico publicado en 2001

D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2018

DAYS ALIVE OUT OF HOSPITAL WITH INITIAL INVASIVE VS CONSERVATIVE MANAGEMENT IN THE ISCHEMIA TRIAL

scientific article published in 2021

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

article

Data on eligibility for thrombolytic treatment can indeed be generalised

artículo científico publicado en 1997

Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes

scientific article published on 01 December 2018

Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from GUSTO-IIb

artículo científico publicado en 1999

Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?

artículo científico publicado en 2000

Deconstructing the Paradox of Smoking and Improved Short-Term Cardiovascular Outcomes After Myocardial Infarction

scientific article published on 01 April 2020

Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials

artículo científico publicado en 2018

Depression and cardiovascular morbidity and mortality: cause or consequence? ⬇️

artículo científico publicado el 1 de noviembre de 2003

Design and methodology of the Occluded Artery Trial (OAT).

artículo científico publicado en 2005

Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial

artículo científico publicado en 2000

Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention.

scientific article published on 26 February 2009

Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention

artículo científico publicado en 2010

Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes

artículo científico publicado en 2012

Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronar

artículo científico publicado en 1997

Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI.

scientific article published on 05 August 2013

Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary

artículo científico

Diagnostic application of the universal definition of myocardial infarction in the intensive care unit

scientific article published on October 2008

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

artículo científico publicado en 2016

Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial

artículo científico publicado en 1997

Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.

artículo científico publicado en 2008

Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction

artículo científico publicado en 2006

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

artículo científico publicado en 2017

Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine

artículo científico publicado en 2007

Direct thrombin inhibitors as adjuncts to thrombolytic therapy

artículo científico publicado en 1999

Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction

artículo científico publicado en 2018

Dithering over the treatment of diabetics with acute myocardial infarction

artículo científico publicado en 2000

Does infection have a role in the pathogenesis of coronary artery disease?

artículo científico publicado en 2000

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial ⬇️

artículo científico publicado el 9 de octubre de 2010

Drug insight: Statin use in the elderly

artículo científico publicado en 2006

Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.

artículo científico publicado en 2016

Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization

artículo científico publicado en 2017

Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction

scientific article published on 01 February 2002

Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial.

artículo científico publicado en 2018

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

artículo científico publicado en 2004

Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction

artículo científico publicado en 1998

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

artículo científico publicado en 2006

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

artículo científico publicado en 1999

Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial

artículo científico publicado en 2009

Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock

article

Editorial: do we need another bleeding definition? What does the Bleeding Academic Research Consortium definition have to offer?

artículo científico publicado en 2011

Editorial: why inhibition of lipoprotein-associated phospholipase A2 has the potential to improve patient outcomes

artículo científico publicado en 2010

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis

artículo científico publicado en 2016

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

artículo científico publicado en 2020

Effect of Alirocumab on Mortality After Acute Coronary Syndromes

artículo científico publicado en 2019

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

scientific article published on 11 November 2019

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2016

Effect of age on outcome with primary angioplasty versus thrombolysis

article

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

artículo científico publicado en 2019

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

artículo científico publicado en 2020

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial

artículo científico publicado en 2014

Effect of aortic valve replacement on c-reactive protein in nonrheumatic aortic stenosis

artículo científico publicado en 2003

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data

artículo científico publicado en 2013

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

artículo científico

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

scientific article published on 01 March 1989

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

scientific article published on 01 October 1987

Effect of platelet inhibition with cangrelor during PCI on ischemic events

artículo científico publicado en 2013

Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients

artículo científico publicado en 2016

Effect of six months' exercise training on C-reactive protein levels in healthy elderly subjects

scientific article published on 1 December 2004

Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis

scientific article published on 01 June 2011

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in My

artículo científico publicado en 2009

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

artículo científico publicado en 2013

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

scientific article published on 01 September 2019

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

scientific article published on 01 July 2019

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

artículo científico publicado en 2019

Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

artículo científico

Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow

artículo científico publicado en 1999

Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk

artículo científico publicado en 2006

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

artículo científico publicado en 2018

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

artículo científico publicado en 2006

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study

scientific article published on 01 December 2000

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study

artículo científico publicado en 2004

Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression

artículo científico publicado en 1995

Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction

artículo científico publicado en 2014

Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.

artículo científico publicado en 2016

Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial

artículo científico publicado en 2016

Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50.

artículo científico

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

artículo científico publicado en 2015

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin,

artículo científico publicado en 2006

Elderly patients should not be denied fibrinolytic therapy

artículo científico publicado en 2007

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel

artículo científico

Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial

artículo científico publicado en 2004

Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials

artículo científico publicado en 2006

End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function

scientific article published on 01 December 1994

End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angi

artículo científico publicado en 1997

Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial

artículo científico publicado en 2010

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatmen

artículo científico publicado en 2005

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

artículo científico publicado en 2006

Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial

artículo científico publicado en 2009

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

artículo científico publicado en 2004

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

artículo científico publicado en 2006

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

artículo científico publicado en 2004

Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.

artículo científico publicado en 2007

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

artículo científico publicado en 2005

Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials

artículo científico publicado en 2016

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki

artículo científico publicado en 1995

Evidence-based assessment of the benefit of revascularisation in coronary disease: beyond the randomised trials

artículo científico publicado en 1996

Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMI

artículo científico publicado en 2022

Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?

artículo científico publicado en 2008

ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis

artículo científico publicado en 2007

Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure).

artículo científico publicado en 2014

Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits

artículo científico publicado en 2016

Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

article published in 2006

Facilitated percutaneous coronary intervention: is this strategy ready for implementation?

artículo científico publicado en 2005

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

artículo científico publicado en 2013

Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials

scientific article published on 29 November 2018

Failure of implementation of the National Heart Foundation of New Zealand guidelines for the management of dyslipidaemia

artículo científico publicado en 1996

Fibrinolysis for Acute Myocardial Infarction in the Elderly Patient: Is it Effective or Too Dangerous?

artículo científico publicado en 1998

First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.

artículo científico

Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression.

artículo científico publicado en 1999

Fourth Universal Definition of Myocardial Infarction (2018)

scientific article published on 01 November 2018

Fourth Universal Definition of Myocardial Infarction (2018)

scientific article published on 25 August 2018

Fourth Universal Definition of Myocardial Infarction (2018)

artículo científico publicado en 2018

Fourth universal definition of myocardial infarction (2018)

article by Kristian Thygesen et al published 25 August 2018 in European Heart Journal

Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial

artículo científico publicado en 2015

Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques

artículo científico publicado en 2006

Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

artículo científico publicado en 2003

Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions

artículo científico publicado en 2015

Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy

scientific article published on 01 January 1995

Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction

artículo científico publicado en 2005

Further evidence that antithrombotic therapy is beneficial with streptokinase: improved early ST resolution and late patency with enoxaparin

artículo científico publicado en 2002

Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.

artículo científico publicado en 2009

Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

artículo científico publicado en 2009

Gender and acute myocardial infarction: is there a different response to thrombolysis?

artículo científico publicado en 1997

Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies

artículo científico publicado en 2022

Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

artículo científico publicado en 2006

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

artículo científico publicado en 2015

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

artículo científico publicado en 2016

Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand

artículo científico publicado en 1993

HORIZONS trial: a step forward for primary percutaneous coronary intervention

artículo científico publicado en 2009

Has the mortality rate from acute myocardial infarction fallen substantially in recent years?

scientific article published on 01 May 2002

Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Corona

artículo científico publicado en 2016

Heart disease in Soweto: facing a triple threat

artículo científico publicado en 2008

Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes

artículo científico publicado en 2013

Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry

artículo científico publicado en 2005

Heart, lung and circulation: flagship or millstone?

scientific article published on 01 March 2004

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

artículo científico publicado en 2010

High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial

artículo científico publicado en 2016

High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction

artículo científico publicado en 2015

High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

artículo científico publicado en 2008

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial

artículo científico publicado en 2005

High-sensitivity cardiac troponin T in stable patients undergoing pharmacological stress testing.

artículo científico publicado en 2015

High-sensitivity troponin level pre-catheterization predicts adverse cardiovascular outcomes after primary angioplasty for ST-elevation myocardial infarction

artículo científico publicado en 2014

Higher mortality in women undergoing coronary artery bypass grafting

artículo científico publicado en 2013

Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial infarction be made?

artículo científico publicado en 2010

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

artículo científico publicado en 2011

Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study

artículo científico publicado en 1998

How Can You Have a Myocardial Infarction Without Significant Coronary Artery Disease?

scientific article published on 01 June 2018

INTERNATIONAL COMPARISONS OF HEALTH STATUS OUTCOMES IN PATIENTS UNDERGOING INITIAL INVASIVE VERSUS CONSERVATIVE MANAGEMENT FOR CHRONIC CORONARY DISEASE: INSIGHTS FROM THE ISCHEMIA TRIAL

scientific article published in 2023

Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel

artículo científico publicado en 2016

Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention

artículo científico publicado en 2017

Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome

artículo científico publicado en 2014

Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention

article

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial

artículo científico publicado en 2008

Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial

artículo científico publicado en 2009

Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HO

artículo científico publicado en 2011

Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urge

scientific article published on 01 June 2011

Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials

artículo científico publicado en 2015

Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).

artículo científico publicado en 2014

Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial

artículo científico publicado en 2011

Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage str

artículo científico publicado en 2009

Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial

artículo científico publicado en 2015

Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial

artículo científico publicado en 2010

Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).

artículo científico publicado en 2009

Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry

scientific article published on 09 January 2020

Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock

scientific article published on 18 January 2007

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the C

artículo científico publicado en 2018

Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.

artículo científico publicado en 2007

Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).

artículo científico publicado en 2014

Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial

artículo científico publicado en 2014

Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial

artículo científico publicado en 2015

Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience

artículo científico publicado en 2016

Implications of the new definition of myocardial infarction

artículo científico publicado en 2005

Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

artículo científico publicado en 2000

Implications of the universal definition of myocardial infarction

artículo científico publicado en 2008

Importance of frailty in patients with cardiovascular disease

artículo científico publicado en 2014

Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin

artículo científico publicado en 2002

Improving cardiovascular care for indigenous populations

artículo científico publicado en 2010

Improving cardiovascular risk assessment

artículo científico publicado en 2011

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

artículo científico publicado en 2020

In the transition from fibrinolysis to primary PCI, the HERO trials help refine STEMI ECG interpretation and Q wave analysis potentially alters future management

artículo científico publicado en 2018

Inadequate control of lipid levels in patients with a previous myocardial infarction

artículo científico publicado en 1998

Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome

artículo científico publicado en 2004

Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial

artículo científico publicado en 2011

Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction

artículo científico publicado en 2014

Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibitio

artículo científico publicado en 2018

Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non–ST-elevation acute coronary syndromes undergoing diagnostic angiography

article

Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy

artículo científico publicado en 2005

Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2013

Increased myocardial ischemia after food is not explained by endothelial dysfunction

artículo científico publicado en 2002

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

artículo científico publicado en 2003

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

artículo científico publicado en 2017

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

artículo científico publicado en 1997

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators

artículo científico publicado en 2000

Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study

artículo científico publicado en 2003

Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial

artículo científico publicado en 2014

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators

scientific article published on 01 December 2000

Initial Invasive or Conservative Strategy for Stable Coronary Disease

scientific article published on 30 March 2020

Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2

artículo científico publicado en 2006

Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy

artículo científico publicado en 2007

Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial

scientific article published on 27 July 2020

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

artículo científico publicado en 2021

International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS

scientific article published on 28 August 2019

International variation in invasive care of the elderly with acute coronary syndromes.

artículo científico publicado en 2006

International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes.

artículo científico publicado en 2007

International variation in the use of evidence-based medicines for acute coronary syndromes

artículo científico publicado en 2003

Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials

artículo científico publicado en 2007

Intravenous platelet blockade with cangrelor during PCI.

artículo científico publicado en 2009

Introduction

Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding

Is our method of obtaining consent appropriate for randomised controlled trials in acute myocardial infarction?

artículo científico publicado el 8 de agosto de 1997

Is there an acceptable ceiling for bleeding for an antithrombotic drug dose to be tested in a phase 3 trial?

artículo científico publicado en 2009

Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarct

artículo científico publicado en 1996

Is thrombolytic therapy really better than conventional treatment in acute inferior myocardial infarction?

artículo científico publicado en 1995

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

scientific article published on 15 October 2013

Ischaemic heart disease

artículo científico publicado en 1994

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy

artículo científico

Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.

artículo científico publicado en 2004

Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial

artículo científico publicado en 2008

Lack of relationship between obesity and mortality or morbidity after coronary artery bypass grafting

artículo científico publicado en 2013

Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases

artículo científico publicado en 2016

Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.

artículo científico publicado en 2013

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

artículo científico publicado en 1987

Left ventricular function as an end-point of thrombolytic therapy

artículo científico publicado en 1990

Left ventricular function following thrombolytic therapy for myocardial infarction

artículo científico publicado en 1995

Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis

artículo científico publicado en 2010

Left-ventricular function as an end-point

artículo científico publicado en 1989

Lessons learned from a clinical trial

artículo científico publicado en 2004

Letter by Mehran et al Regarding Article, “Bleeding Academic Research Consortium Consensus Report: The Food and Drug Administration Perspective”

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

artículo científico publicado en 1995

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

artículo científico publicado en 2021

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

artículo científico publicado en 2020

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2016

Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization

scientific article published on 31 August 2020

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study

artículo científico publicado en 2016

Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction

artículo científico publicado en 2011

Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries

artículo científico publicado en 1997

Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2014

Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY mana

artículo científico publicado en 2015

Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience

Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction

scientific article published on 01 January 1994

Long-term survival and valve-related complications in young women with cardiac valve replacements.

artículo científico publicado en 1999

Longitudinal study of a 9p21.3 SNP using a national electronic healthcare database

article

Low molecular weight heparins in acute ischaemic syndromes

artículo científico publicado en 1998

Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial

artículo científico publicado en 2018

Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease

artículo científico publicado en 2018

Magnetic Resonance Imaging and Troponin Elevation Following Percutaneous Coronary Intervention

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization

artículo científico

Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries

artículo científico publicado en 2002

Management of acute myocardial infarction in Auckland

artículo científico publicado en 1996

Management of myocardial infarction

artículo científico publicado en 1994

Management of non ST-elevation acute coronary syndrome patients in New Zealand: a longitudinal analysis. Results from the New Zealand Acute Coronary Syndrome national audits of 2002, 2007 and 2012

artículo científico publicado en 2016

Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit

artículo científico publicado en 2004

Management of suspected acute coronary syndrome patients admitted to cardiology or non-cardiology services at Auckland City Hospital: implications for future national data collection.

artículo científico publicado en 2018

Maori have worse outcomes after coronary artery bypass grafting than Europeans in New Zealand

artículo científico publicado en 2013

Mechanical Properties of Five Long Stents Compared

artículo científico publicado en 1998

Medical treatment for acute coronary syndromes

artículo científico publicado en 2000

Meta-Analysis of Bleeding Scores Performance for Acute Coronary Syndrome

artículo científico publicado en 2020

Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes

artículo científico publicado en 2015

Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

artículo científico publicado en 2003

Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

artículo científico publicado en 2020

Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study

artículo científico publicado en 2014

Misconceptions about cholesterol

artículo científico publicado en 1990

Missed opportunities for better health outcomes in New Zealand

scientific article published on 06 August 2004

Modest Improvement of Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction Networks With Rapid Care Process Implementation but no Effect on Mortality

artículo científico publicado en 2017

Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial

scientific article published in 2022

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

artículo científico publicado en 2002

Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries

scientific article published on 01 December 1994

Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons

scientific article published on 03 December 2020

Myocardial infarction following sclerotherapy in a patient with a patent foramen ovale

artículo científico publicado en 2012

Myocardial infarction: why can't we get the diagnosis right?

artículo científico publicado en 2003

N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes

artículo científico publicado en 2004

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial

artículo científico publicado en 1999

Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy

artículo científico publicado en 1993

New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST-elevation myocardial infarction

artículo científico publicado en 2000

New ST-depression: an under-recognized high-risk category of 'complete' ST-resolution after reperfusion therapy

artículo científico publicado en 2012

New antiplatelet agents

artículo científico publicado en 1998

New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience

artículo científico publicado en 2000

New insights into the pathogenesis, prevention and management of acute coronary syndromes

artículo científico publicado en 1996

Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis

artículo científico publicado en 1993

Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels

artículo científico publicado en 1996

Noninvasive, medical management for non-ST-elevation acute coronary syndromes

artículo científico publicado en 2008

Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

Occluded infarct-related arteries and clinical events

artículo científico publicado en 2000

One-Year Survival Following Early Revascularization for Cardiogenic Shock

scientific article published in The Journal of the American Medical Association

One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial

artículo científico publicado en 2010

One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators

scientific article published on 01 September 1996

Ongoing clinical trials of anti-platelet agents in the management of acute ischaemic coronary syndromes

artículo científico publicado en 1998

Oral antiplatelet therapy for atherothrombotic disease: Current evidence and new directions ⬇️

artículo científico publicado el 1 de marzo de 2011

Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

artículo científico publicado en 1994

Outcomes after ST-elevation myocardial infarction presentation to hospitals with or without a routine primary percutaneous coronary intervention service (ANZACS-QI 46)

scientific article published on 30 October 2020

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients

scientific article published on 09 May 2013

Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial

artículo científico publicado en 2009

Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial

artículo científico publicado en 2008

Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)

scientific article published on 19 July 2018

Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes

artículo científico publicado en 2006

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials

artículo científico publicado en 2004

Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]).

artículo científico publicado en 2015

Overview and determinants of cardiovascular disease in indigenous populations

artículo científico publicado en 2010

P3640Association of ceramide and phospholipid levels and cardiovascular events in stable coronary heart disease: findings from the STABILITY Biomarkers substudy ⬇️

scholarly article

PHARMAC and lack of funding for clopidogrel

artículo científico publicado en 2005

PHARMAC and the statin debacle

artículo científico publicado en 2006

PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION

article

Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?

artículo científico publicado en 2011

Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002

artículo científico publicado en 2010

Patients with circumflex occlusions miss out on reperfusion: how to recognize and manage them

artículo científico publicado en 2012

Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy

artículo científico publicado en 2007

Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)

Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes

artículo científico publicado en 2005

Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.

artículo científico publicado en 2003

Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

artículo científico publicado en 2014

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial

artículo científico publicado en 2020

Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y12 Inhibitor Pretreatment

artículo científico publicado en 2019

Persistent psychological distress and mortality in patients with stable coronary artery disease

artículo científico publicado en 2017

Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents

artículo científico publicado en 1993

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib

artículo científico publicado en 2017

Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study

artículo científico publicado en 2009

Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome

artículo científico publicado en 2009

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

artículo científico publicado en 2005

Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial

artículo científico publicado en 2016

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2017

Physical activity in patients with stable coronary heart disease: an international perspective

artículo científico publicado en 2013

Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease

artículo científico publicado en 2013

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy

artículo científico publicado en 2012

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

scientific article published on 01 September 2002

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

artículo científico publicado en 2002

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

scientific article published in The Lancet

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

artículo científico publicado en 2001

Platelet inhibition with cangrelor in patients undergoing PCI.

artículo científico publicado en 2009

Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals

artículo científico publicado en 2016

Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials)

artículo científico publicado en 2006

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

scientific article published on 01 July 2020

Post-systolic shortening: a marker of potential for early recovery of acutely ischaemic myocardium in the dog.

artículo científico publicado en 1987

Postmenopausal hormone use in women with acute coronary syndromes

artículo científico publicado en 2004

Postsystolic shortening of acutely ischemic canine myocardium predicts early and late recovery of function after coronary artery reperfusion.

artículo científico publicado en 1988

Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction

artículo científico publicado en 2003

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

artículo científico publicado en 2012

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial

artículo científico publicado en 2013

Prasugrel, Māori, and personalised medicine in New Zealand

artículo científico publicado en 2010

Pravastatin Therapy and the Risk of Stroke

article

Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.

artículo científico publicado en 2002

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes

artículo científico

Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage

artículo científico publicado en 1998

Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

artículo científico publicado en 2020

Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2008

Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial

scientific article published on 01 February 2011

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes

artículo científico publicado en 2003

Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model

artículo científico publicado en 2017

Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study

scientific article published on October 2008

Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy

artículo científico

Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.

artículo científico publicado en 2006

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes

scientific article published on 08 November 2006

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study

artículo científico publicado en 2008

Prehospital thrombolysis.

artículo científico publicado en 2001

Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24

scientific article published on 20 June 2019

Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction

artículo científico publicado en 2000

Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.

artículo científico publicado en 2008

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

artículo científico publicado en 2017

Prioritizing waiting lists

scientific article published on 01 May 2000

Prognosis after recovery from myocardial infarction: the relative importance of cardiac dilatation and coronary stenoses ⬇️

artículo científico publicado el 1 de diciembre de 1992

Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial

artículo científico publicado en 2014

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

artículo científico publicado en 2018

Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

artículo científico publicado en 2005

Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial

artículo científico publicado en 2005

Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial

artículo científico

Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome

artículo científico publicado en 2014

Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial

artículo científico publicado en 2011

Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Interven

artículo científico publicado en 2009

Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes.

artículo científico publicado en 2009

Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial).

artículo científico publicado en 2014

Prognostic value of lead V1 ST elevation during acute inferior myocardial infarction

artículo científico publicado en 2010

Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease

artículo científico

Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).

artículo científico publicado en 2002

Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators

artículo científico publicado en 1999

Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?

artículo científico publicado en 2017

Prospective evaluation of a chest pain pathway at Green Lane Hospital

artículo científico publicado en 2002

Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction

artículo científico publicado en 1996

Prosthetic heart valves and pregnancy

artículo científico publicado en 2003

Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

artículo científico publicado en 2017

Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution

article

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

artículo científico publicado en 2017

Public sensationalism and clinical trials: how to address the challenges of science?

artículo científico publicado en 2010

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

artículo científico publicado en 2019

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

artículo científico publicado en 2018

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

artículo científico publicado en 2018

Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial

artículo científico publicado en 2013

Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy

artículo científico publicado en 2011

Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)

artículo científico publicado en 2001

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron

artículo científico publicado en 1998

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using [...]

artículo científico publicado en 2002

Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators

artículo científico publicado en 1997

Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial

artículo científico publicado en 2013

Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial

article

Recognising "painless" heart attacks

artículo científico publicado en 2002

Recommendations arising from the inaugural CSANZ Conference on Indigenous Cardiovascular Health

artículo científico publicado en 2010

Redefining medical treatment in the management of unstable angina

artículo científico publicado en 2000

Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction

artículo científico publicado en 2012

Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction

artículo científico publicado el 1 de junio de 1992

Reducing the lifetime cardiovascular risk of New Zealanders

artículo científico publicado en 2007

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.

artículo científico publicado en 2014

Regression of atherosclerosis: fact or fiction?

artículo científico publicado el 11 de diciembre de 1991

Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort

artículo científico publicado en 2012

Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking

artículo científico publicado en 1990

Relation between blood pressure after an acute coronary event and subsequent cardiovascular risk

artículo científico publicado en 2002

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

artículo científico publicado en 2004

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

artículo científico publicado en 2021

Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial

artículo científico publicado en 2005

Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators

artículo científico publicado en 1996

Relation of initial platelet counts to Thrombolysis In Myocardial Infarction-3 flow rates at 90 minutes after commencing fibrinolytic therapy in patients with acute myocardial infarction

artículo científico publicado en 2002

Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction

artículo científico publicado en 2004

Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIA

artículo científico publicado en 2008

Relation of pathologic Q waves at presentation and time to streptokinase therapy with early changes in infarct-related artery flow and ventricular wall motion

artículo científico publicado en 2001

Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes

artículo científico

Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction

artículo científico publicado en 2000

Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase

artículo científico publicado en 2003

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

artículo científico publicado en 2002

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.

artículo científico publicado en 2009

Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes

artículo científico publicado en 2016

Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial

artículo científico publicado en 2008

Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction

artículo científico publicado en 2010

Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks

artículo científico publicado en 2005

Reply to Letter Regarding Article, “The Impact of Collateral Flow to the Occluded Infarct-Related Artery on Clinical Outcomes in Patients With Recent Myocardial Infarction: A Report From the Randomized Occluded Artery Trial”

Reply to letter by Kirat and Kӧse: Maximizing information from a 12-lead electrocardiogram

artículo científico publicado en 2015

Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?

artículo científico publicado en 2014

Republished: clinical implications of the third universal definition of myocardial infarction

artículo científico publicado en 2014

Research in the Antipodes at Green Lane

artículo científico publicado en 2020

Resolution of ST depression after fibrinolysis can be more important than resolution of ST elevation for many patients with inferior STEMIs

artículo científico publicado en 2014

Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction

artículo científico publicado en 2009

Response to 'lifetime cardiovascular risk' letter

artículo científico publicado en 2011

Response to NZMJ editorial by Dr Elana Curtis entitled Deserving of more: framing of Māori inequities in cardiovascular care remain a challenge

artículo científico publicado en 2013

Response to letters regarding article, “Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy”

artículo científico publicado en 2011

Restrictive physiology in cardiogenic shock: Observations from echocardiography

artículo científico publicado en 2006

Results of percutaneous coronary angioplasty in patients <40 years of age

artículo científico publicado en 1998

Rheumatic heart disease in indigenous populations

artículo científico publicado en 2010

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

artículo científico publicado en 2019

Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease

scientific article published on 02 January 2021

Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I

scientific article published on 01 March 1998

Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).

artículo científico publicado en 2004

Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin

artículo científico publicado en 2002

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial

article

Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes

artículo científico publicado en 2002

Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy

scientific article published on 14 August 2006

Risk stratification of patients with right ventricular infarction: is there a need for a specific risk score?

artículo científico publicado en 2002

Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries

artículo científico publicado en 1999

Rivaroxaban for the treatment of acute coronary syndromes

artículo científico publicado en 2013

Robin Mackenzie Norris

artículo científico publicado en 2015

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

artículo científico

Ruling-In Myocardial Injury and Ruling-Out Myocardial Infarction With the European Society of Cardiology 1-Hour Algorithm

artículo científico publicado en 2016

ST deviations and serial changes after reperfusion therapy in patients with inferior STEMIs: Relationship between inferior leads, medial chest leads and lateral leads

artículo científico publicado en 2015

ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy

scientific article published on 01 May 2000

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

artículo científico publicado en 2008

STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment

artículo científico publicado en 2010

Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Interventio

artículo científico publicado en 2008

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

artículo científico publicado en 2004

Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction

artículo científico publicado en 1990

Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and

artículo científico publicado en 2008

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

artículo científico publicado en 2012

See-sawing cardiovascular risk factors: a call for action in New Zealand.

artículo científico publicado en 2006

Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators

artículo científico publicado en 1997

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2017

Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart Disease

artículo científico publicado en 2016

Serum troponins T and I after elective cardioversion

artículo científico publicado en 2000

Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.

artículo científico publicado en 2015

Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial

artículo científico publicado en 2018

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

artículo científico publicado en 2017

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS

artículo científico publicado en 2018

Sex differences in mortality following acute coronary syndromes

artículo científico publicado en 2009

Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators

artículo científico publicado en 1999

Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years

artículo científico publicado en 2015

Sharing Data from Cardiovascular Clinical Trials--A Proposal

artículo científico publicado en 2016

Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials

artículo científico publicado en 2017

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

artículo científico publicado en 2008

Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

artículo científico publicado en 2003

Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?

artículo científico publicado en 2005

Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial

artículo científico publicado en 2003

Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

artículo científico publicado en 1993

Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

artículo científico publicado en 1993

Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease

artículo científico publicado en 1990

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS

scientific article published on 03 September 2019

Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy.

artículo científico publicado en 2018

Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion

artículo científico publicado en 2002

Smoking and acute myocardial infarction

artículo científico publicado en 1993

Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction

scientific article published on 01 April 1999

Smoking: back to the future - again?

scientific article published on 01 October 2000

Society's expectation of the role of the doctor in New Zealand: results of a national survey

artículo científico publicado en 2011

Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial

artículo científico publicado en 2016

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

artículo científico publicado en 2011

State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease

artículo científico publicado en 2016

Statin use and sex-specific stroke outcomes in patients with vascular disease

artículo científico publicado en 2006

Stent deformation following simulated side-branch dilatation: a comparison of five stent designs

artículo científico publicado en 1999

Strategies to minimize bleeding complications of percutaneous coronary intervention

artículo científico publicado en 2009

Streptokinase and lifestyle outcome in survivors of myocardial infarction

artículo científico publicado el 13 de mayo de 1992

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

artículo científico publicado en 2018

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

artículo científico publicado en 1995

Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome

article by Michelle L. O'Donoghue et al published October 2011 in American Heart Journal

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

artículo científico publicado en 2010

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY

article by Chee Tang Chin et al published July 2010 in American Heart Journal

Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

artículo científico publicado en 2020

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

article

Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy

artículo científico publicado en 1999

Surgical Risk Scores for Coronary Artery Bypass Grafting: with Focus on AusSCORE I and II

artículo científico publicado en 2018

Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks

artículo científico publicado en 1999

Survival After Invasive or Conservative Management of Stable Coronary Disease

scientific article published in 2023

Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial

artículo científico publicado en 2000

Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES

artículo científico publicado en 2020

Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes

artículo científico publicado en 2002

Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial

artículo científico publicado en 2003

Systems of care: need for hub and spoke systems of care for patients with myocardial infarction. A call for action

artículo científico publicado en 2010

Systems of care: need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis

scientific article published on 01 July 2008

THE EFFECT OF PLATELET INHIBITON BY CANGRELOR AMONG OBESE PATIENTS UNDERGOING CORONARY STENTING: INSIGHTS FROM THE CHAMPION TRIALS

artículo científico publicado en 2019

Targeting therapy to the fibrin-mediated pathophysiology of acute coronary syndrome

artículo científico

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico

Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failur

artículo científico

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

artículo científico publicado en 2016

The ATOLL trial of enoxaparin in primary percutaneous coronary intervention ⬇️

artículo científico publicado el 1 de diciembre de 2010

The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)

artículo científico

The Cardiac Society Inaugural Cardiovascular Health Conference: conference findings and ways forward.

artículo científico publicado en 2010

The HERO-2 ECG sub-studies in patients with ST elevation myocardial infarction: implications for clinical practice

artículo científico publicado en 2013

The Role of Lipoprotein-Associated Phospholipase A2 as a Marker and Potential Therapeutic Target in Atherosclerosis ⬇️

artículo científico publicado el 1 de abril de 2011

The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design

article

The corrected TIMI frame count. The new gold standard?

artículo científico publicado en 1998

The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.

artículo científico publicado en 2006

The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes

artículo científico publicado en 2005

The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX

artículo científico publicado en 2015

The effect of transcutaneous electrical nerve stimulation on coronary and systemic haemodynamics in syndrome X

scientific article published on 01 July 1996

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

artículo científico publicado en 2006

The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX

artículo científico publicado en 2019

The evolving role of direct thrombin inhibitors in acute coronary syndromes

artículo científico publicado en 2003

The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events

artículo científico publicado en 2002

The forgotten lead: does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients?

artículo científico publicado en 2013

The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55)

scholarly article

The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction

artículo científico publicado en 2006

The impact of postrandomization crossover of therapy in acute coronary syndromes care

artículo científico

The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial

artículo científico

The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional care

artículo científico publicado en 2013

The prequel: defining prognostically important criteria in the periprocedural PCI troponin saga

artículo científico publicado en 2012

The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction

artículo científico publicado en 2011

The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes

artículo científico publicado en 2002

The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial

article

The relationship between meteorological conditions and index acute coronary events in a global clinical trial

artículo científico publicado en 2013

The role of antihypertensive therapy in the decline in stroke mortality

scientific article published on 01 September 1987

The role of natriuretic peptides in patients with chronic complex (mixed or multiple) heart valve disease

artículo científico publicado en 2010

The roles for coronary surgery and angioplasty in the management of patients with stable angina: evidence and decision making

scientific article published on 01 May 1998

The universal definition of myocardial infarction: a consensus document: ischaemic heart disease

artículo científico publicado en 2008

The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

artículo científico publicado en 2008

The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study

artículo científico publicado en 2008

Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment

artículo científico publicado en 1988

Things ain't what they used to be: impact of a new definition of myocardial infarction

artículo científico publicado en 2002

Third Universal Definition of Myocardial Infarction

artículo científico publicado en 2012

Third Universal Definition of Myocardial Infarction

article

Third universal definition of myocardial infarction

artículo científico publicado en 2012

Third universal definition of myocardial infarction

artículo científico publicado en 2012

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

artículo científico publicado en 2011

Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries

artículo científico publicado en 1998

Thrombolysis: an effective therapy in acute coronary thrombosis.

artículo científico publicado en 1986

Thrombolytic eligibility.

artículo científico publicado en 1998

Thrombolytic therapy and recurrent myocardial infarction

artículo científico publicado en 1990

Thrombolytic therapy for acute myocardial infarction in the elderly

artículo científico publicado en 2000

Thrombolytic therapy for acute myocardial infarction--round 2

artículo científico publicado en 1988

Thrombolytic therapy in acute myocardial infarction

artículo científico publicado en 1994

Thrombolytic therapy in the elderly. Pharmacoeconomic considerations

artículo científico publicado en 1996

Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.

artículo científico publicado en 2011

Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial

artículo científico publicado en 2019

Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial

scientific article published on 03 March 2018

Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.

artículo científico publicado en 2018

Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

artículo científico publicado en 2007

Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial

artículo científico

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making

scientific article published on 01 January 2003

Tooth loss is independently associated with poor outcomes in stable coronary heart disease

artículo científico publicado en 2015

Torrent of troponin

artículo científico publicado en 2014

Towards a new order in cardiovascular medicine: re-engineering through global collaboration

article

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

artículo científico publicado en 2017

Trans-fatty acids in New Zealand patients with coronary artery disease

artículo científico publicado en 2011

Treating menstruating women with thrombolytic therapy: Insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial

article

Treatment of myocardial infarction by early lysis of intracoronary thrombi

artículo científico publicado en 1985

Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation

artículo científico publicado en 1991

Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials

artículo científico publicado en 2016

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years

artículo científico publicado en 2012

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

artículo científico publicado en 1999

Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery

artículo científico publicado en 2011

Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

artículo científico publicado en 2010

Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50.

artículo científico publicado en 2016

Universal MI definition update for cardiovascular disease

artículo científico publicado en 2014

Universal definition of myocardial infarction

artículo científico publicado en 2007

Universal definition of myocardial infarction

artículo científico publicado en 2007

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

artículo científico publicado en 2007

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials

artículo científico publicado en 2011

Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes

artículo científico publicado en 2003

Use of creatine kinase isoforms for diagnosis of infarct artery patency after thrombolytic therapy with streptokinase

scientific article published on 01 February 1993

Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials

artículo científico publicado en 2007

Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial

artículo científico publicado en 2013

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

artículo científico publicado en 2016

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

artículo científico publicado en 2014

Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction

artículo científico publicado en 2002

Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction

artículo científico publicado en 1999

Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26)

scientific article published on 13 March 2020

Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI

artículo científico publicado en 2011

VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context

artículo científico publicado en 2003

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

artículo científico publicado en 2016

Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction.

artículo científico publicado en 2007

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

artículo científico publicado en 2003

Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes

scientific article published on 21 March 2005

Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial

scientific article published on June 2016

Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women

artículo científico publicado en 2007

Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.

artículo científico publicado en 2008

Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2.

artículo científico publicado en 2007

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

artículo científico publicado en 2017

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

artículo científico publicado en 2013

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).

artículo científico publicado en 2014

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

artículo científico publicado en 2014

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.

artículo científico publicado en 2014

Waiting room computer tablets to improve health literacy and cardiovascular outcomes

artículo científico publicado en 2021

Waiting times and prioritization for coronary artery bypass surgery in New Zealand.

artículo científico publicado en 1999

Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes

artículo científico publicado en 2010

We must use the knowledge that we have to treat patients with acute coronary syndromes

scientific article published on 01 February 2004

We should cap the health budget and spend more money on housing and food: NO.

artículo científico publicado en 2012

What contribution has cardiac surgery made to the decline in mortality from coronary heart disease?

artículo científico publicado en 1987

White blood cell count predicts reduction in coronary heart disease mortality with pravastatin

artículo científico publicado en 2005

Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2017

Will new higher-precision troponins lead to clarity or confusion?

scientific article published on July 2008

Withdrawal of statins in patients with acute coronary syndromes

scientific article published on 01 January 2003

Withdrawal of statins increases event rates in patients with acute coronary syndromes

artículo científico publicado en 2002

Women and coronary heart disease

artículo científico publicado en 1993

[Fourth universal definition of myocardial infarction (2018)]

artículo científico publicado en 2018

[Universal definition of the myocardial infarction].

artículo científico publicado en 2008

aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction

artículo científico publicado en 2010

Lista de obras de Harvey D. White

"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction

2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006.

2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006.

2212Body mass index and its association to cardiovascular outcomes in patients with stable coronary heart disease - experiences from the STABILITY study ⬇️

30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18).

A case of cardiogenic shock caused by capecitabine treatment

A catalog of genetic loci associated with kidney function from analyses of a million individuals

A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012

A direct threat to research in public hospitals

A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement

A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial

A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction

A randomized trial evaluating the effects of change in dairy food consumption on cardio-metabolic risk factors.

A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis

A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction

A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry

A simulation of warfarin maintenance dose requirement using a pharmacogenetic algorithm in an ethnically diverse cohort

A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes

ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients

Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity

Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial

Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale

Acute Coronary Care in the Elderly, Part I

Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities.

Acute Myocardial Infarction: Fibrinolytic Therapy

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Ger

Acute myocardial infarction

Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry

Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

Acute myocardial infarction: a true medical emergency

Acute reperfusion for ST-elevation myocardial infarction in New Zealand (2015-2017): patient and system delay (ANZACS-QI 29)

Adding Insult to Injury: Are There Treatments for Myocardial Injury and Type 2 Myocardial Infarction?

Adherence and outcomes: it's more than taking the pills

Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective

Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction

Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the I

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.

Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial

All-Cause Mortality Following an Acute Coronary Syndrome: 12-Year Follow-Up of the Comprehensive 2002 New Zealand Acute Coronary Syndrome Audit

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction

Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial ⬇️

Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction

Antiplatelet drug nonresponsiveness

Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction

Antithrombin agents as adjuncts to thrombolytic therapy

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial

Antithrombotic therapy in ST-segment elevation myocardial infarction ⬇️

Apixaban with antiplatelet therapy after acute coronary syndrome

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome

Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Isch

Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy

Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis

Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes ⬇️

Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial

Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome

Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

Availability of troponin testing for cardiac patients in New Zealand 2002 to 2011: implications for patient care.

Avatar of the universal definition of periprocedural myocardial infarction

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

Benefit of Early Sustained Reperfusion in Patients With Prior Myocardial Infarction (The GUSTO-I Trial)